Sunifiram is a relatively new entry into the Nootropics field, although its first studies and results were published back in 2000. This supplement is actually fairly similar to Piracetam (the original Nootropic) in structure, but it does have a much higher potency which is reported to be around 1,000 times stronger.
Preliminary findings from CBD oil studies show a 32-45% decline in seizures. This post from MPR discusses the CBD oil studies and their results.
Summary: "We are confident that we can make a difference" The Turkish Petroleum Overseas Company (TPOC), a wholly owned subsidiary of Turkish Petroleum Corporation (TPAO), says it has recently started to see the fruitful results of the aggressive exploration work it has conducted in Libya since 2000.
BREAKING NEWS: Promising initial results have been announced from ReveraGen BioPharma's clinical trial of Vamorolone, a 'designer corticosteroid' with the potential to cause fewer side effects and produce greater benefits than other steroids that are commonly prescribed to slow the progression of Duchenne muscular dystrophy.
The researchers predicted that PET scan information would lead to changes in patient management in 30 percent of the cases. In fact, results from almost 4,000 participants showed the scan information changed the patient management plan over 67 percent of the time.
Many translated example sentences containing "initial promising results" – German-English dictionary and search engine for German translations.
Early results show promising signs of clinical activity, including improvements in disease burden, accompanied by an exceptional safety profile and dosing regimen that causes almost no patient burden. The results of this study will be reported in detail at future scientific forums.
The Turkish Petroleum Overseas Company (TPOC), a wholly owned subsidiary of Turkish Petroleum Corporation (TPAO), says it has recently started to see the fruitful results of the aggressive exploration
In the research noted here, scientists have identified a potential treatment for cataracts based on the details of a rare human mutation that causes cataracts to form in young children. These patients lack lanosterol, and for reasons not yet fully understood that causes cataract formation in the
LONDON (UK), December 2018 — A new therapy aimed at improving the sight of people with one of the most common forms of childhood blindness has shown "very promising" initial results, according to a study involving University College London (UCL) researchers.
We all know how popular avocados are around the world, some of us like the green while other prefer the black skins, and probably the most well known is the Hass variety. Well, there is a newcomer ...
Just under four months into its science phase MMS is delivering promising early results on a kind of magnetic explosion that's related to everything from the northern lights to solar flares.
2010-01-31· Initial impressions are that this is a cheap rifle! Mag looks cheap, stock looks cheap and the barrel was favoring one side of the barrel channel. I cleaned that up so there is no contact of steel to plastic. After all that I put a 6-18x scope on and got it zeroed with 37 gr of varget under 120 gr Amax. Let the wife shoot a group which was pretty nice but with a flier. Cleaned it again, loaded ...
New treatment for multiple sclerosis has promising initial results. Tuesday November 27 2018
POET Partners with Wavetek, Cites Promising Initial Results. January 27th, 2016. SAN JOSE, CA, and HSINCHU SCIENCE PARK, TAIWAN, R.O.C. (MARKETWIRED, January 27, 2016) – POET Technologies Inc. (the "Company" or "POET") (OTCQX: POETF; TSX Venture: PTK) a developer of opto-electronics fabrication processes for the semiconductor industry ...
The information on this Website is not reliable and not intended to provide tax, legal, or investment advice. Nothing contained on the Website shall be considered a recommendation, solicitation, or offer to buy or sell a security to any person in any jurisdiction.
New treatment for multiple sclerosis has promising initial results. Home New treatment for multiple sclerosis has promising initial results
Since Merck-Medco Managed Care's Partners for Healthy Aging program hit the phones in May, physician response to pharmacists' calls regarding the drug therapy of senior citizen patients has been positive, officials from the pharmacy benefit manage (PBM) told Drug Topics.
MacArthur, RD 2007, ' Darunavir: promising initial results ' Lancet, vol. 369, no. 9568, pp. 1143-1144. https://doi.org/10.1016/S0140-6736(07)60499-1
Fura Gems Inc. ("Fura" or the "Company") (FURA) announces the initial results of its Diamond Drilling Program, and provides updates of its operations, at the Coscuez Emerald Project in Boyac ...
The sirolimus-eluting bioresorbable peripheral scaffold system designed to treat stenoses and occlusion in the superficial femoral artery will be clinically evaluated in the DESappear trial. An update on the trial, which is enrolling, was presented by Andrew Holden (Auckland, New Zealand).
Jenex is a progressive medical device technology company focused on providing consumers with quality medical devices that address their dermatological needs. Clear and healthy skin for all is at ...
The initial results seemed promising, but the final effects were kind of disappointing. In the given sentence above, the unnecessary qualifier that needs to be removed is "kind of".
A new therapy aimed at improving the sight of people with one of the most common forms of childhood blindness, has shown 'very promising' initial results, according to a study involving UCL researchers.
Multiple Sclerosis "Hope for multiple sclerosis patients as scientists discover attacking the glandular fever virus can combat symptoms," reports the Mail Online.
NIJMEGEN, The Netherlands I September 28, 2015 I Synthon Biopharmaceuticals ('Synthon') reports positive initial results from the dose-escalation part of its ongoing first-in-human trial with SYD985, an investigational HER2-targeting antibody-drug conjugate (ADC). Partial responses were observed
A breast-cancer treatment based on MIT radar research is now in Phase II clinical trials, and preliminary results to be reported at a September 24 meeting look promising.
Initial results are promising and help to set the stage forimplementation of evidence-based, cost-effective approaches toreducing the severity of and mortality of S4 • Compliance Analysis results demonstrate a strong correlation between increased compliance to …
2018-12-14· Rimiducid-activated GoCAR-T ® resulted in significant expansion and persistence of T cells. Initial evidence of biologic activity and stable disease.
Toronto, Ontario--(Newsfile Corp. - October 12, 2017) - The Jenex Corporation (TSXV: JEN.H) ("Jenex" or the "Company"), a progressive medical device technology company, today announces that it has received promising initial results on the Zika virus testing with TherOZap™